Buprenorphine for Heroin Addicts

Clark H W . 2003. Office-based practice and opioid-use disorders. N Engl J Med, 349: 928–930.

Rosenblum A , Magura S and Joseph H. 1991. Ambivalence towards methadone treatment among intravenous drug users. J Psychoactive Drugs, 23: 21–27.

Zule W A and Desmond D P . 1998. Attitudes toward methadone maintenance: Implications for HIV prevention. J Psychoactive Drugs, 30: 89–97.

Office of National Drug Control Policy. 2000. National Drug Control Strategy, Washington, DC: Government Printing Office. 2000

Johnson R E , Chutuape A M , Strain E C , Walsh S L , Stitzer M L and Bigelow G E . 2000. A comparison of levomethadyl acetate, buprenorphine, and methadone for opioid dependence. N Engl J Med, 343: 1290–1297.

Strain E C , Stitzer M L , Liebson I A and Bigelow G E . 1996. Buprenorphine versus methadone in the treatment of opioid dependence: Self-reports, urinalysis, and addiction severity index. J Clin Psychopharmacol, 16: 58–67.

Ling W , Wesson D R , Charuvastra C and Klett C J . 1996. A controlled trial comparing buprenorphine and methadone maintenance in opioid dependence. Arch Gen Psychiatry, 53: 401–407.

Fudala P J , Bridge T P , Herbert S , Williford W O , Chiang C N , Jones K , Collins J , Raisch D , Casadonte P , Goldsmith R J , Ling W , Malkerneker U , McNicholas L , Renner J , Stine S and Tusel D. 2003. Office-based treatment of opiate addiction with a sublingual-tablet formulation of buprenorphine and naloxone. N Engl J Med, 349: 949–958.

Mattick R P , Ali R , White J M , O'Brien S , Wolk S and Danz C. 2003. Buprenorphine versus methadone maintenance therapy: A randomized double-blind trial with 405 opioid-dependent patients. Addiction, 98: 441–452.

Auriacombe M , Fatseas M , Dubernet J , Daulouede J P and Tignol J. 2004. French field experience with buprenorphine. The American Journal on Addictions, 13: S17–S28.

Vignau J , Duhamel A , Catteau J , Lega G , Pho A H , Grailles I , Beauvillain J , Petit P , Beauvillain P and Parquet P J . 2001. Practice-based buprenorphine maintenance treatment (BMT): How do French healthcare providers manage the opiate-addicted patient?. Journal of Substance Abuse Treatment, 21: 135–144.

Thirion X , Lapierre V , Micallef J , Ronfle E , Masut A , Pradel V , Coudert C , Mabriez J C and Sanmarco J L . 2002. Buprenorphine prescription by general practitioners in a French region. Drug and Alcohol Dependence, 65: 197–204.

Johnson R E , Eissenberg T , Stitzer M L , Strain E C , Liebson I A and Bigelow G E . 1995. A placebo controlled clinical trial of buprenorphine as a treatment for opioid dependence. Drug Alcohol Depend, 40: 17–25.

Schottenfeld R S , Pakes J R and Kosten T R . 1998. Prognostic factors in buprenorphine versus methadone maintained patients. J Nerv Ment Dis, 186: 35–43.

Ling W , Charuvastra C , Collins J F , Batki S , Brown L S , Kintaudi P , Wesson D R , McNicholas L , Tusel D J , Malkerneker U , Renner J A , Santos E , Casadonte P , Fye C , Stine S , Wang R IH and Segal D. 1998. Buprenorphine maintenance treatment of opiate dependence: A multicenter, randomized clinical trial. Addiction, 93: 475–486.

Galanter M , Dermatis H , Glickman L , Maslansky R , Sellers M B , Neumann E and Rahman-Dujarric C. 2004. Network therapy: Decreased secondary opioid use during buprenorphine maintenance. J Subst Abuse Treat, 26: 313–318.